Quick answers
- What is Norpace?
- Norpace is a brand name of Disopyramide phosphate, a prescription medicine. The FDA NDC Directory lists 2 Norpace products in 2 strengths and forms.
- Who makes Norpace?
- Pfizer holds the FDA application for Norpace (NDA017447, approved September 1, 1977).
- Is there a generic or store brand of Norpace?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Norpace product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Norpace been recalled?
- FDA enforcement reports list 2 recalls of Norpace products; the newest started December 2, 2015. A recall usually concerns specific lots, not every product.
What Norpace is
Each Norpace product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Disopyramide phosphate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| disopyramide phosphate 100 mg capsule, gelatin coated (oral) | Norpace | 1 product, 1 company | DailyMed |
| disopyramide phosphate 150 mg capsule, gelatin coated (oral) | Norpace | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Disopyramide phosphate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA017447 | Pfizer | September 1, 1977 | 2 |
Companies that list Norpace
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Norpace products.
- Pfizer Laboratories Div Pfizer Inc2 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 2, 2015 · Class III · Terminated · D-0520-2016
Failed Dissolution Specification
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Divisio — Pfizer Inc.
-
May 31, 2013 · Class III · Terminated · D-607-2013
Failed Dissolution Specification
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Divisio — Pfizer Inc
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.